Skip to main content.
Skip to content

Medicare GLP-1 Bridge: What Agents Need to Tell Clients Before July 1

The Medicare GLP-1 Bridge starts July 1, and your Medicare clients are about to have a lot of questions. The program gives eligible beneficiaries access to certain weight loss drugs for $50 a month, and the news coverage is everywhere. 

The clients calling you will not understand the fine print. The details that trip people up are exactly where you can show your value heading into AEP. Here is what the Medicare GLP-1 Bridge actually does, who qualifies, and how to talk about it.


What the Medicare GLP-1 Bridge Is

The Medicare GLP-1 Bridge is a time-limited demonstration program from CMS. It runs from July 1, 2026 through December 31, 2027. During that window, eligible Medicare beneficiaries can get certain GLP-1 weight loss medications for a flat $50 per month.

The program covers a specific list of drugs: Wegovy in both injection and pill form, the KwikPen version of Zepbound, and the newer Foundayo pill. The list is not every GLP-1 on the market, so a client on a different product may not be covered under the Bridge.


Who Qualifies

Eligibility comes down to body weight and health status. A beneficiary generally qualifies with a BMI of 27 or higher plus a qualifying condition. Those conditions include prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease.

Two more requirements matter. The medication has to be prescribed for weight loss and paired with ongoing lifestyle changes. And a doctor has to submit prior authorization to a CMS central processor before the client can access the program.

 


The Part D Requirement Most Clients Will Miss

Here is the piece that will surprise people. To access the Bridge at all, the beneficiary has to be enrolled in a Medicare Part D plan. No Part D, no program.

That single requirement is where you come in. A client who wants GLP-1 access and is not in a Part D plan now has a concrete reason to review their coverage with you. This is not a hypothetical AEP conversation. It is a specific, motivated request, and you are the person who can sort it out.


The Three Things That Confuse Clients

The copay details are counterintuitive, and clients will get them wrong. Walk them through these:

1. The $50 does not count toward the Part D cap or deductible. It sits outside the standard benefit, so it will not help a client reach their out-of-pocket maximum faster. A client expecting this to push them toward their catastrophic threshold will be disappointed.

2. Extra Help does not apply. Low-income subsidy recipients pay the same $50. No assistance program lowers it further, and the price stays the same regardless of which Part D phase the client is in.

3. It runs through CMS, not their plan. The doctor submits prior authorization to a CMS central processor, not the client's Part D carrier. Clients who call their plan first will get told nobody knows what they are talking about, which causes confusion and frustration.


Who Is Left Out

The Bridge is a Part D demonstration, so some beneficiaries cannot use it directly. People in PACE programs, certain cost plans, or private fee-for-service plans are not eligible unless they also have a standalone Part D plan. If you have clients in those arrangements who ask about the program, that is the first thing to check.


Why This Matters for Your Book

You do not sell the drugs, so it is fair to ask why this belongs on your radar. The answer is Part D relevance and trust.

Every client who wants GLP-1 access needs to be in a Part D plan, which makes their coverage worth reviewing with you. And the agent who can explain the eligibility rules and the copay quirks clearly is the agent that client trusts when AEP arrives. The clients who hear about this from a news segment will come in with half the story. Being the person who gives them the full, accurate picture is how you earn the next conversation.


The Bottom Line

The Medicare GLP-1 Bridge starts July 1, 2026 and runs through the end of 2027, offering $50 access to specific weight loss drugs for beneficiaries who meet the BMI and health criteria and are enrolled in a Part D plan. The copay does not count toward the Part D cap, Extra Help does not apply, and the program runs through CMS rather than the client's carrier. The agents who understand these details will field the questions cleanly and turn a news headline into a coverage conversation.

If you want a faster way to review Part D options with clients asking about the Bridge, Quotit lets you compare plans in minutes.  

New call-to-action

Disclaimer: This post is for educational purposes only and reflects information available at the time of publication. 

Recent Blogs

Take your insurance business to the next level with Quotit